XML 77 R65.htm IDEA: XBRL DOCUMENT v3.20.4
Note 14 - Related Party Transactions (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2017
Dec. 14, 2017
Dec. 02, 2017
Jul. 12, 2017
Notes Receivable, Related Parties, Current $ 17,901        
Long-term Convertible Notes Payable to Multiple Private Investors [Member]            
Debt Instrument, Interest Rate, Stated Percentage           5.00%
CEN Biotech Ukraine [Member] | XN Pharma [Member]            
Ownership Percentage       49.00%    
CEN Biotech Ukraine [Member]            
Percentage of Related Party's Equity Interest Owned by Director       25.50%    
Business Acquisition, Percentage of Voting Interests Acquired       51.00%    
Emergence Global [Member]            
Notes Receivable, Related Parties, Current $ 17,901          
Joseph Byrne [Member]            
Percentage of Related Party's Equity Interest Owned 5.00%          
CEN Biotech Ukraine [Member]            
Due from Related Parties, Total $ 1,079,328 1,065,328        
Percentage of Related Party's Equity Interest Owned by Director         51.00%  
CEN Biotech Ukraine [Member] | Equipment Sold to Related Party in Exchange for Note Receivable [Member]            
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings     $ 255,141      
Notes Receivable, Related Parties     44,859      
Board Members and Officers [Member] | Consulting Fees [Member]            
Related Party Transaction, Amounts of Transaction 124,800 154,517        
Due to Related Parties, Total $ 330,200 $ 263,900        
R&D Labs Canada, Inc [Member] | Purchased Equipment in Exchange for Note Payable [Member]            
Notes Payable, Related Parties     $ 300,000